Captopril and Remeron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Captopril (captopril) and Remeron (mirtazapine). Common drug interactions include abasia among females and diabetes mellitus among males.

The phase IV clinical study analyzes what interactions people have when they take Captopril and Remeron. It is created by eHealthMe based on reports of 50 people who take the same drugs from the FDA, and is updated regularly.

What is Captopril?

Captopril has active ingredients of captopril. It is often used in high blood pressure. eHealthMe is studying from 17,438 Captopril users. Check the latest studies of Captopril.

What is Remeron?

Remeron has active ingredients of mirtazapine. It is often used in depression. eHealthMe is studying from 26,474 Remeron users. Check the latest studies of Remeron.



On Jul, 12, 2026

50 people who take Captopril and Remeron together, and have interactions are studied.

Captopril and Remeron drug interactions.

What are the common drug interactions of Captopril and Remeron, by gender? *:

female:

  1. Abasia (inability to walk)
  2. Cardiovascular disorder (heart diseases)
  3. Nausea (feeling of having an urge to vomit)
  4. Organ failure
  5. Overdose
  6. Kidney infection
  7. Renal failure chronic (long lasting kidney dysfunction)
  8. Abdominal pain
  9. Cardiac arrest
  10. Confusional state

male:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  2. Obesity (having too much body fat)
  3. Gout (uric acid crystals building up in the body)
  4. Headache (pain in head)
  5. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  6. Hyperkalaemia (damage to or disease of the kidney)
  7. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  8. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  9. Pancreatitis (inflammation of pancreas)
  10. Prostate cancer

What are the common drug interactions of Captopril and Remeron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Transplant rejection (a transplant material is not worked)
  2. Type 2 diabetes mellitus
  3. Arthralgia (joint pain)
  4. C-reactive protein increased
  5. Gout (uric acid crystals building up in the body)
  6. Hyperkalaemia (damage to or disease of the kidney)
  7. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  8. Pancreatitis (inflammation of pancreas)
  9. Type 1 diabetes mellitus
  10. Cholecystitis acute (rapid infection of gallbladder)

50-59:

  1. Diabetic complication
  2. Electrocardiogram t wave inversion
  3. Headache (pain in head)
  4. Hyperlipidaemia (presence of excess lipids in the blood)
  5. Loss of consciousness
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  8. Nausea (feeling of having an urge to vomit)
  9. Obesity (having too much body fat)
  10. Tachycardia (a heart rate that exceeds the range of 100 beats/min)

60+:

  1. Colitis (inflammation of colon)
  2. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  3. Fall
  4. Headache (pain in head)
  5. Hypoxia (low oxygen in tissues)
  6. Nausea (feeling of having an urge to vomit)
  7. Nephrolithiasis (calculi in the kidneys)
  8. Syncope (loss of consciousness with an inability to maintain postural tone)
  9. Abdominal pain
  10. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 13 people, 26.00%
  2. Stress And Anxiety: 10 people, 20.00%
  3. Type 2 Diabetes: 8 people, 16.00%
  4. Sleep Disorder: 7 people, 14.00%
  5. Pain: 7 people, 14.00%
  6. Diabetes: 7 people, 14.00%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 12.00%
  8. Urinary Tract Infection: 4 people, 8.00%
  9. Infection: 4 people, 8.00%
  10. Hypersensitivity: 4 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Captopril and Remeron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Captopril and Remeron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Captopril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Remeron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Captopril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Remeron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on captopril and mirtazapine (the active ingredients of Captopril and Remeron, respectively), and Captopril and Remeron (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: